Hypertensive Renal Injury
Hypertensive Renal Injury
批准号:
7513392
负责人:
PETER A DORIS
金额:
$35.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-25 至 2011-07-31
关键词:
AllelesAmericanAnimal ModelBreedingCardiovascular DiseasesChromosome MappingChronicCongenic StrainControl LocusDNA ResequencingDiabetes MellitusDialysis procedureDiseaseDyslipidemiasEnd stage renal failureGenerationsGenesGenetic Predisposition to DiseaseGenetic VariationHeredityHypertensionInbred SHR RatsIndividualInjuryInsulin ResistanceKidneyKidney DiseasesKidney TransplantationMapsModelingOxidation-ReductionPathway interactionsPatientsPlayPopulationPredispositionRattusRelative (related person)Renal dialysisResistanceResolutionRiskRoleSingle Nucleotide PolymorphismSpeedStressSyndromeTestingVariantcardiovascular disorder riskcongenicdensitydiabeticdiabetic patientgenome-widemortalityprogramspublic health relevance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Over 400,000 Americans have end-stage renal disease (ESRD) requiring dialysis or kidney transplant for survival. ESRD in the US population doubled in the last decade and this increase is driven by diabetes and hypertension. ESRD is associated with very high rates of mortality, most frequently from cardiovascular disease (CVD), and the heightened risk of CVD in individuals with chronic renal injury means that they are much more likely to die of CVD than to progress to ESRD. There is great variation in risk for ESRD among individuals who have hypertension and/or diabetes. The major determinant of this variation in risk is genetic susceptibility that serves to enhance the capacity of hypertension and diabetes to generate renal injury. The proposed studies focus on an animal model of renal injury with concurrent hypertension, insulin resistance and dyslipidemia, the spontaneously hypertensive rat (SHR). This model recapitulates the role of genetic susceptibility to renal injury in hypertensive and diabetic patients: the SHR-A3 line acquires hypertensive renal injury, while other hypertensive SHR lines resist it. These contrasting SHR lines offer a valuable means to identify the mechanism of and the genes contributing to susceptibility to renal injury. The proposed studies are made possible by our recent progress in defining a set of high density, single nucleotide polymorphism (SNP) markers in our injury-prone (SHR-A3) and resistant (SHRB2) lines that allow high resolution genetic mapping of loci controlling susceptibility to renal injury. We propose here to use these markers to map an intercross of these parental lines that will identify injury susceptibility loci. The conclusions of our mapping study will be tested and verified by breeding reciprocal congenic strains that fix injury resistance and susceptibility alleles in the injury-prone SHR-A3 and the injury-resistant SHR-B2 lines. Finally, we have uncovered the role of renal redox stress in the generation of renal injury in SHR-A3 and identified a transcriptional program that leads to this redox stress. This provides an opportunity to refine our genetic mapping studies down to the level of specific genes within the mapped loci. Genes that are functionally correlated to the transcriptional pathway of renal redox stress that we have elucidated in SHR-A3 will be targeted for selective resequencing to identify specific gene variants that drive the renal injury pathway. PUBLIC HEALTH RELEVANCE Kidney injury caused by diabetes and high blood pressure requires that more than 400,000 Americans be treated by kidney dialysis in order to survive. Heredity plays a major role in risk of kidney injury. Among diabetic and high blood pressure patients, the largest risk of progressive kidney disease is the occurrence of this disease in a relative. In the proposed studies we will use a rat model of this syndrome to genetically map chromosomal regions harboring genes that create risk of kidney injury. By uncovering the genes that cause this injury in rats and how this injury is created by these genes we will open up valuable new opportunities to understand the disease in people and to envision and test new treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Long-read assembly and annotation of rat genomes that are important models of complex genetic disease
-
批准号:10449388
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2021
-
负责人:PETER A DORIS
-
依托单位:
Long-read assembly and annotation of rat genomes that are important models of complex genetic disease
-
批准号:10211748
-
项目类别:
-
资助金额:$45.84万
-
财政年份:2021
-
负责人:PETER A DORIS
-
依托单位:
Long-read assembly and annotation of rat genomes that are important models of complex genetic disease
-
批准号:10615135
-
项目类别:
-
资助金额:$39.85万
-
财政年份:2021
-
负责人:PETER A DORIS
-
依托单位:
Immunogenetics of Common Polygenic Renal Disease
-
批准号:10471535
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:PETER A DORIS
-
依托单位:
Hypertensive Renal Injury
-
批准号:9129508
-
项目类别:
-
资助金额:$40.32万
-
财政年份:2009
-
负责人:PETER A DORIS
-
依托单位:
Hypertensive Renal Injury
-
批准号:8692749
-
项目类别:
-
资助金额:$45.87万
-
财政年份:2009
-
负责人:PETER A DORIS
-
依托单位:
Hypertensive Renal Injury
-
批准号:7938592
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2009
-
负责人:PETER A DORIS
-
依托单位:
Hypertensive Renal Injury
-
批准号:8918294
-
项目类别:
-
资助金额:$44.56万
-
财政年份:2009
-
负责人:PETER A DORIS
-
依托单位:
Hypertensive Renal Injury
-
批准号:8494186
-
项目类别:
-
资助金额:$49.31万
-
财政年份:2009
-
负责人:PETER A DORIS
-
依托单位:
Hypertensive Renal Injury
-
批准号:9336160
-
项目类别:
-
资助金额:$39.4万
-
财政年份:2009
-
负责人:PETER A DORIS
-
依托单位:
Hypertensive Renal Injury
-
批准号:8536193
-
项目类别:
-
资助金额:$10.02万
-
财政年份:2009
-
负责人:PETER A DORIS
-
依托单位:
HNF1 transcriptional control of renal oxidative stress
-
批准号:7474737
-
项目类别:
-
资助金额:$27.66万
-
财政年份:2005
-
负责人:PETER A DORIS
-
依托单位:
HNF1 transcriptional control of renal oxidative stress
-
批准号:6985142
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2005
-
负责人:PETER A DORIS
-
依托单位:
HNF1 transcriptional control of renal oxidative stress
-
批准号:7669170
-
项目类别:
-
资助金额:$27.92万
-
财政年份:2005
-
负责人:PETER A DORIS
-
依托单位:
HNF1 transcriptional control of renal oxidative stress
-
批准号:7104205
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2005
-
负责人:PETER A DORIS
-
依托单位:
HNF1 transcriptional control of renal oxidative stress
-
批准号:7270670
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2005
-
负责人:PETER A DORIS
-
依托单位:
CARDIAC GLYCOSIDES FROM THE ADRENAL GLAND
-
批准号:6022105
-
项目类别:
-
资助金额:$3.89万
-
财政年份:1999
-
负责人:PETER A DORIS
-
依托单位:
CARDIAC GLYCOSIDES FROM THE ADRENAL GLAND
-
批准号:2745352
-
项目类别:
-
资助金额:$3.79万
-
财政年份:1998
-
负责人:PETER A DORIS
-
依托单位:
CARDIOTONIC STEROIDS FROM THE ADRENAL GLAND
-
批准号:6517246
-
项目类别:
-
资助金额:$19.8万
-
财政年份:1997
-
负责人:PETER A DORIS
-
依托单位:
CARDIAC GLYCOSIDES FROM THE ADRENAL GLAND
-
批准号:2016564
-
项目类别:
-
资助金额:$3.52万
-
财政年份:1997
-
负责人:PETER A DORIS
-
依托单位:
海外基金